Skip to content

Penetrating needling combined with Lijin tuina based on the theory of "Jingjin" for temporomandibular joint disorder syndrome: a clinical randomized controlled trial

Penetrating needling combined with Lijin tuina based on the theory of "Jingjin" for temporomandibular joint disorder syndrome: a clinical randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000454
Enrollment
Unknown
Registered
2025-03-04
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Temporomandibular Joint Disorder Syndrome

Interventions

Treatment group:penetrating needling combined with?Lijin tuina
Control group:Take pills of Diclofenac Sodium

Sponsors

Pidu District Hospital of Traditional Chinese medicine in Chengdu Sichuan Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for temporomandibular joint disorder syndrome in Oral and maxillofacial Surgery (5th Edition); 2. Duration =12 months; 3. Age 18-60; 4. Normal cognitive function and understanding ability; 5. No history of drug treatment for TMJ disorder syndrome in the past 1 week; 6. Voluntarily participate in clinical observation strictly abide by the treatment methods prescribed in this study obey the doctor's arrangement and insist on cooperating with treatment and follow-up.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the above diagnostic criteria and inclusion criteria. 2. Observers who have received other relevant treatments that may affect the indicators of this study. 3. Patients under 18 years of age or over 60 years of age. 4. Pregnant women with other life-threatening primary diseases such as cardiovascular and cerebrovascular liver kidney and hematopoietic system. 5. Patients with a history of temporomandibular joint surgery or trauma and complicated diseases such as tumor tuberculosis or joint injury. 6. Patients who do not treat according to the regulations cannot judge the efficacy or have incomplete data that affect the efficacy and safety judgment.

Design outcomes

Primary

MeasureTime frame
Friction function index;

Secondary

MeasureTime frame
Efficacy evaluation;Recurrence Rate;VAS pain score;

Countries

China

Contacts

Public ContactWang Jiaping

Pidu District Hospital of TCM

275552031@qq.com13628050018

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026